In the fiscal year 2022, Astellas Pharma's operating profit amounted to approximately 286.9 billion Japanese yen, the highest number of the past decade. Within the observed period, figures peaked previously at approximately 277.7 billion yen in fiscal 2018 but then receded in the following three fiscal years.
The main areas of the Japanese pharmaceutical company include urology, immunology, cardiology, and infectious diseases.
Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022
(in billion Japanese yen)
fiscal year 2013 to 2022; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
Special properties
consolidated data
Supplementary notes
Astellas Pharma Inc. has adopted International Financial Reporting Standards (IFRS) since the fiscal year ended March 31, 2014. Figures up to fiscal year ended March 31 2014, are based on Japanese generally accepted accounting principles (J-GAAP).
Figures prior to FY 2021 come from the previous reporting.
100 Japanese yen equal 0.72 U.S. dollars or 0.67 euros as of June 2023.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Astellas. (April 27, 2023). Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/
Astellas. "Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in billion Japanese yen)." Chart. April 27, 2023. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/
Astellas. (2023). Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in billion Japanese yen). Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/
Astellas. "Operating Profit of Astellas Pharma Inc. from Fiscal Year 2013 to 2022 (in Billion Japanese Yen)." Statista, Statista Inc., 27 Apr 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/
Astellas, Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in billion Japanese yen) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/ (last visited September 20, 2024)
Operating profit of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph], Astellas, April 27, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/825667/astellas-pharma-operating-income/